tumor tissue array slides Search Results


90
Crown Bioscience tumor tissue array slides
Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) <t>Tissue</t> <t>array</t> <t>slides</t> containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.
Tumor Tissue Array Slides, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/tumor+tissue+array+slides/pmc07774737-78-0-7
Average 90 stars, based on 1 article reviews
tumor tissue array slides - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc a multiple organ tumor tissue array slide
Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) <t>Tissue</t> <t>array</t> <t>slides</t> containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.
A Multiple Organ Tumor Tissue Array Slide, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/a+multiple+organ+tumor+tissue+array+slide/pmc04126265-67-0-11
Average 90 stars, based on 1 article reviews
a multiple organ tumor tissue array slide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
U.S Biomax Inc immunofluorescence tissue-array slides of human breast and colorectal tumor
Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) <t>Tissue</t> <t>array</t> <t>slides</t> containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.
Immunofluorescence Tissue Array Slides Of Human Breast And Colorectal Tumor, supplied by U.S Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/Colorectal+cancer(CRC)+with+matched+cancer+adjacent+or+adjacent+normal+tissue+array%2C+containing+metastatic+carcinoma%2C+including+pathology+grade%2C+TNM+and+clinical+stage%2C+65+cases%2F100+cores%2C+replacing+CO1002b/pmc03123374-82-7-12
Average 90 stars, based on 1 article reviews
immunofluorescence tissue-array slides of human breast and colorectal tumor - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pantomics Inc human brain tumor tissue array slide
Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) <t>Tissue</t> <t>array</t> <t>slides</t> containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.
Human Brain Tumor Tissue Array Slide, supplied by Pantomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tumor+tissue+array+slides/human+brain+tumor+tissue+array+slide/pm27629530-122-0-6
Average 90 stars, based on 1 article reviews
human brain tumor tissue array slide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) Tissue array slides containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.

Journal: Cancer Medicine

Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer

doi: 10.1002/cam4.3554

Figure Lengend Snippet: Staining of non‐small cell lung cancer (NSCLC) cells and tissues by 16A (specific to GSTA neoantigen), SM3, and C595 (specific to PDTR neoantigen). (A) NSCLC cell lines were stained with 16A, SM3, and C595 antibodies. (B) Tissue array slides containing consecutive tissue sections from the same NSCLC patients were stained with 16A, SM3, and C595 antibodies.

Article Snippet: Tumor tissue array slides were obtained from CrownBio.

Techniques: Staining

Expression of the aberrantly glycosylated MUC1 peptide motif in lung and breast cancer tissues upon 16A antibody staining. (A) H‐score of the cancer tissue array stained with the 16A antibody. The intensity of IHC staining was scored at four levels: 0 (negative), 1 (weak staining), 2 (medium staining), and 3 (strong staining). The percentages of tumor cells at different intensity levels were evaluated. Total Score = (% at 0) ×0 + (% at 1) × 1 + (% at 2) ×2 + (% at 3) × 3. (B) 16A positivity in lung cancer, breast cancer, and triple‐negative breast cancer (TNBC) samples. (C, D, E, F) Representative photographs of MUC1 immunostaining in peritumoral (C), lung cancer (D), Non‐TNBC (E), and TNBC (F) tissue with the 16A antibody (original magnification ×200). Positivity was defined as ≥30% of tumor with staining ≥2+.

Journal: Cancer Medicine

Article Title: An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer

doi: 10.1002/cam4.3554

Figure Lengend Snippet: Expression of the aberrantly glycosylated MUC1 peptide motif in lung and breast cancer tissues upon 16A antibody staining. (A) H‐score of the cancer tissue array stained with the 16A antibody. The intensity of IHC staining was scored at four levels: 0 (negative), 1 (weak staining), 2 (medium staining), and 3 (strong staining). The percentages of tumor cells at different intensity levels were evaluated. Total Score = (% at 0) ×0 + (% at 1) × 1 + (% at 2) ×2 + (% at 3) × 3. (B) 16A positivity in lung cancer, breast cancer, and triple‐negative breast cancer (TNBC) samples. (C, D, E, F) Representative photographs of MUC1 immunostaining in peritumoral (C), lung cancer (D), Non‐TNBC (E), and TNBC (F) tissue with the 16A antibody (original magnification ×200). Positivity was defined as ≥30% of tumor with staining ≥2+.

Article Snippet: Tumor tissue array slides were obtained from CrownBio.

Techniques: Expressing, Staining, Immunohistochemistry, Immunostaining